Hypermarcas (OTCMKTS:HYPMY) Sees Strong Trading Volume – Still a Buy?

Hypermarcas (OTCMKTS:HYPMY) shares saw unusually-high trading volume on Friday . Approximately 28,871 shares were traded during trading, an increase of 25% from the previous session’s volume of 23,057 shares.The stock last traded at $4.61 and had previously closed at $4.63.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised Hypermarcas to a “hold” rating in a research report on Wednesday, April 29th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy”.

Hypermarcas Stock Down 1.7%

The firm’s fifty day simple moving average is $4.47 and its 200 day simple moving average is $4.52. The company has a current ratio of 1.27, a quick ratio of 0.84 and a debt-to-equity ratio of 0.61. The company has a market cap of $3.20 billion, a price-to-earnings ratio of 9.48 and a beta of 0.73.

Hypermarcas (OTCMKTS:HYPMY) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.10 earnings per share for the quarter. The business had revenue of $383.13 million for the quarter. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%. Sell-side analysts predict that Hypermarcas will post 0.53 earnings per share for the current year.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.